Web-based interventions in multiple sclerosis: the potential of tele-rehabilitation by Alexander Tallner, Klaus Pfeifer, Mathias Mäurer

Get full text

Acute intermittent porphyria (AIP) in a patient with celiac disease by Sebastian Nunnemann, Christoph Uibel, Petra Budig, Mathias Mäurer

Get full text

PD-1 regulates neural damage in oligodendroglia-induced inflammation. by Antje Kroner, Nicholas Schwab, Chi Wang Ip, Christoph Leder, Klaus-Armin Nave, Mathias Mäurer, Heinz Wiendl, Rudolf Martini

Get full text

OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany by Tjalf Ziemssen, Stephan Richter, Mathias Mäurer, Mathias Buttmann, Boris Kreusel, Anne-Maria Poehler, Maren Lampl, Ralf A. Linker

Get full text

Correction: PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation. by Antje Kroner, Nicholas Schwab, Chi Wang Ip, Christoph Leder, Klaus-Armin Nave, Mathias Mäurer, Heinz Wiendl, Rudolf Martini

Get full text

The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis by Marie Wunsch, Christopher Hohmann, Bianca Milles, Christina Rostermund, Paul V. Lehmann, Michael Schroeter, Antonios Bayas, Jochen Ulzheimer, Mathias Mäurer, Süleyman Ergün, Stefanie Kuerten

Get full text

Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis. by Sebastian Doerck, Kerstin Göbel, Gesa Weise, Tilman Schneider-Hohendorf, Michael Reinhardt, Peter Hauff, Nicholas Schwab, Ralf Linker, Mathias Mäurer, Sven G Meuth, Heinz Wiendl

Get full text

Molecular Ultrasound Imaging of Early Vascular Response in Prostate Tumors Irradiated with Carbon Ions by Moritz Palmowski, Peter Peschke, Jochen Huppert, Peter Hauff, Michael Reinhardt, Mathias Maurer, Christian P. Karger, Michael Scholz, Wolfhard Semmler, Peter E. Huber, Fabian M. Kiessling

Get full text

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) by Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp

Get full text